Biomarkers in congenital heart disease: do natriuretic peptides hold the key?
R Alonso-Gonzalez, K Dimopoulos - Expert Review of …, 2013 - Taylor & Francis
Congenital heart disease is the most common congenital abnormality. The long-term
prognosis of these patients has changed significantly over the last half century, thanks to …
prognosis of these patients has changed significantly over the last half century, thanks to …
Visit-to-Visit B-type natriuretic peptide variability during the previous year has independent prognostic value in patients with stable chronic heart failure
N Kagiyama, T Yuri, A Hayashida, A Hirohata… - Cardiology, 2019 - karger.com
Background: There is wide variability of visit-to-visit (V2V) B-type natriuretic peptide (BNP) in
patients with chronic heart failure (CHF), even when they are stable. The prognostic …
patients with chronic heart failure (CHF), even when they are stable. The prognostic …
Pulmonary hypertension: Barrier or just a bump in the road in transplanting adults with congenital heart disease
Background Heart failure (HF) is the leading cause of death in adults with congenital heart
disease (ACHD). Identification of disease progression and timing of referral for advanced …
disease (ACHD). Identification of disease progression and timing of referral for advanced …
Transplantation and mechanical circulatory support in adult congenital heart disease-related advanced heart failure
JN Menachem, LJ Burchill - Heart Failure in Adult Congenital Heart …, 2018 - Springer
Heart transplantation has become an increasingly common and effective therapy for adults
with end-stage congenital heart disease (ACHD) because of advances in patient selection …
with end-stage congenital heart disease (ACHD) because of advances in patient selection …
[PDF][PDF] Adult congenital heart disease in Greece: need for a step forward
G Parcharidis - Hellenic J Cardiol, 2011 - hellenicjcardiol.org
Congenital heart disease (CHD) is common, occurring in~ 8 of 1000 live births, with 90% of
children born with heart defects surviving to adulthood. This has occurred mainly due to the …
children born with heart defects surviving to adulthood. This has occurred mainly due to the …
[引用][C] The aetiology of heart failure
CE Jackson, RS Gardner, CJ Whelan… - Oxford Textbook of …, 2022 - Oxford University Press
Brain natriuretic peptide level in a small series of children and grown-ups with congenital heart defects with chronic cardiac failure
G Grutter, S Alfieri, F Parisi - Cardiology in the Young, 2013 - cambridge.org
The present study assessed the usefulness of brain natriuretic peptide in evaluating the
cardiovascular status in children and grown-ups with congenital or acquired disease …
cardiovascular status in children and grown-ups with congenital or acquired disease …
Medical Therapy for Chronic Right Ventricular Failure in Congenital Heart Disease
SL Roche - Right Ventricular Physiology, Adaptation and Failure in …, 2018 - Springer
The clinical importance of right ventricular (RV) function has been increasingly recognised in
populations with and without congenital heart disease (CHD). CHD patients most at risk of …
populations with and without congenital heart disease (CHD). CHD patients most at risk of …
动脉导管未闭介入封堵前后NT-proBNP 变化及意义
李丽， 方臻飞， 吕春美， 朱丹 - 中西医结合心脑血管病杂志, 2012 - cqvip.com
目的探讨成人动脉导管未闭介入封堵术前, 术后不同时间点血浆氮末端脑钠肽前体(NT-proBNP)
浓度的变化, 及与肺动脉压力变化的规律. 方法选成功行介入封堵术的动脉导管未闭(PDA) …
浓度的变化, 及与肺动脉压力变化的规律. 方法选成功行介入封堵术的动脉导管未闭(PDA) …
检测尿B 型利钠肽在心力衰竭患者预后判断中的价值
符震球， 顾光大 - 医学研究杂志, 2012 - cqvip.com
目的探索尿BNP 在心力衰竭中预后价值. 方法本研究纳入52 例心力衰竭患者, 检测尿BNP
和血浆BNP. 对心力衰竭患者进行心功能分级及心脏超声检查. 统计分析尿BNP 和血浆BNP …
和血浆BNP. 对心力衰竭患者进行心功能分级及心脏超声检查. 统计分析尿BNP 和血浆BNP …